Literature DB >> 1166816

Effects of medium chain triglycerides on portal and arterial levels of insulin, FFA and glucose in patients with pancreatic disease.

S Röjdmark.   

Abstract

Trioctanoin has been given orally to six patients with pancreatic disease and the effects on the portal and arterial levels of insulin, free fatty acids (FFA) and glucose have been investigated. The serum levels of insulin and FFA rose significantly in portal blood but not in arterial blood after trioctanoin. The glucose level in portal as well as in arterial blood remained unaffected by the fat ingestion. The implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1166816     DOI: 10.1111/j.0954-6820.1975.tb19515.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  1 in total

1.  Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial.

Authors:  Samuel T Henderson; Janet L Vogel; Linda J Barr; Fiona Garvin; Julie J Jones; Lauren C Costantini
Journal:  Nutr Metab (Lond)       Date:  2009-08-10       Impact factor: 4.169

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.